BNTC
Benitec Biopharma Inc.
+0.39 (+3.53%)11.43USD25.2K成交股數399M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00-100% | 0.00 | 0.00 | 0.00 | 54K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.3M | 5.8M | 3.4M | 2.9M | 6.5M | 5.4M | 3.6M | 3.5M | 2.6M | 5.1M | 4.4M | 3.2M |
| 銷售管理費用 | 7.3M | 7.5M | 6.4M | 7.0M | 8.8M | 5.4M | 2.2M | 2.0M | 1.6M | 1.8M | 1.6M | 1.2M |
| 營業利益 | −13.6M-11% | −13.4M+24% | −9.8M+69% | −9.8M+77% | −15.3M+270% | −10.8M+56% | −5.8M-1% | −5.5M+28% | −4.1M | −6.9M | −5.9M | −4.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | -8,038.9% |
| 稅後淨利 | −11.9M-18% | −11.8M+24% | −9.0M+77% | −8.8M+87% | −14.5M+239% | −9.6M+41% | −5.1M-15% | −4.7M+7% | −4.3M | −6.8M | −6.0M | −4.4M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | -8,142.6% |
| 稀釋 EPS | -0.24-37% | -0.260% | -0.22+22% | -0.21-104% | -0.38+65% | -0.26-90% | -0.18-94% | 4.70-276% | -0.23 | -2.64 | -3.05 | -2.67 |
| 稀釋股數 | 49.4M | 46.0M | 41.5M | 41.2M | 38.6M | 37.3M | 27.9M | 18.4M | 18.3M | 2.6M | 2.2M | 1.6M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 185M | 189M | 94.5M | 97.7M | 104M | 78.3M | 67.8M | 50.9M | 14.1M | 20.4M | 25.9M | 6.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 187M | 191M | 96.0M | 99.6M | 105M | 79.1M | 68.8M | 52.2M | 15.0M | 21.4M | 27.1M | 8.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.7M | 3.3M | 2.4M | 2.3M | 7.6M | 3.1M | 4.6M | 5.0M | 3.5M | 5.9M | 4.7M | 3.5M |
| 股東權益 | 183M | 187M | 93.6M | 97.3M | 97.6M | 75.9M | 64.2M | 47.2M | 11.5M | 15.5M | 22.3M | 4.7M |
| 負債比 | 2.0% | 1.7% | 2.5% | 2.3% | 7.3% | 4.0% | 6.7% | 9.5% | 23.3% | 27.6% | 17.5% | 42.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −3.4M-27% | – | – | – | −4.6M+0% | – | – | – | −4.6M | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 14K | 14K | 13K | – | 13K | 14K | 25K | 26K | 25K | 17K | 19K | 32K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −45.5M | –% | -0.98 | −16.6M |
| FY2025 | – | – | −37.9M | –% | -1.05 | −23.6M |
| FY2024 | 0.00 | -100.0% | −21.8M | –% | -1.22 | −19.6M |
| FY2023 | 75K | +2.7% | −19.6M | -26,082.7% | -14.12 | −18.0M |
| FY2022 | 73K | +23.7% | −18.2M | -24,942.5% | -37.88 | −15.9M |
| FY2021 | 59K | -42.2% | −13.9M | -23,528.8% | -3.23 | −13.1M |
| FY2020 | 102K | -99.2% | −8.3M | -8,111.8% | -8.10 | −7.6M |
| FY2019 | 12.2M | – | 2.6M | 21.4% | 3.05 | 4.4M |